356 related articles for article (PubMed ID: 36980210)
1. Evaluation and Application of Drug Resistance by Biomarkers in the Clinical Treatment of Liver Cancer.
Huang PS; Wang LY; Wang YW; Tsai MM; Lin TK; Liao CJ; Yeh CT; Lin KH
Cells; 2023 Mar; 12(6):. PubMed ID: 36980210
[TBL] [Abstract][Full Text] [Related]
2. Role of Alpha-Fetoprotein in Hepatocellular Carcinoma Drug Resistance.
Li W; Liu K; Chen Y; Zhu M; Li M
Curr Med Chem; 2021; 28(6):1126-1142. PubMed ID: 32729413
[TBL] [Abstract][Full Text] [Related]
3. The Role of Alpha-Fetoprotein (AFP) in Contemporary Oncology: The Path from a Diagnostic Biomarker to an Anticancer Drug.
Głowska-Ciemny J; Szymański M; Kuszerska A; Malewski Z; von Kaisenberg C; Kocyłowski R
Int J Mol Sci; 2023 Jan; 24(3):. PubMed ID: 36768863
[TBL] [Abstract][Full Text] [Related]
4. The Landscape Of Alpha Fetoprotein In Hepatocellular Carcinoma: Where Are We?
Hu X; Chen R; Wei Q; Xu X
Int J Biol Sci; 2022; 18(2):536-551. PubMed ID: 35002508
[TBL] [Abstract][Full Text] [Related]
5. [Research progress of AFP in the diagnosis and therapy of hepatocellular carcinoma].
Qian L; Li C; Luo Y; Meng S
Sheng Wu Gong Cheng Xue Bao; 2021 Sep; 37(9):3042-3060. PubMed ID: 34622616
[TBL] [Abstract][Full Text] [Related]
6. Current Status and Perspective Biomarkers in AFP Negative HCC: Towards Screening for and Diagnosing Hepatocellular Carcinoma at an Earlier Stage.
Luo P; Wu S; Yu Y; Ming X; Li S; Zuo X; Tu J
Pathol Oncol Res; 2020 Apr; 26(2):599-603. PubMed ID: 30661224
[TBL] [Abstract][Full Text] [Related]
7. [Research progress of serum biomarkers for early screening of hepatocellular carcinoma].
Zhu W; Huang Y
Zhonghua Gan Zang Bing Za Zhi; 2021 Apr; 29(4):308-312. PubMed ID: 33979955
[TBL] [Abstract][Full Text] [Related]
8. Automatic Time-Resolved Fluorescence Immunoassay of Serum Alpha Fetoprotein-L3 Variant via LCA Magnetic Cationic Polymeric Liposomes Improves the Diagnostic Accuracy of Liver Cancer.
Wang K; Li Y; Wang X; Jiao J; Li Y; Gu W; Liang X
Int J Nanomedicine; 2020; 15():4933-4941. PubMed ID: 32764926
[TBL] [Abstract][Full Text] [Related]
9. Sorafenib and hepatocellular carcinoma: is alpha-fetoprotein a biomarker predictive of tumor biology and primary resistance?
Negri F; Gnetti L; Pedrazzi G; Silini EM; Porta C
Future Oncol; 2021 Sep; 17(27):3579-3584. PubMed ID: 34155918
[TBL] [Abstract][Full Text] [Related]
10. Comprehensive evaluation of microRNA as a biomarker for the diagnosis of hepatocellular carcinoma.
Malik J; Klammer M; Rolny V; Chan HL; Piratvisuth T; Tanwandee T; Thongsawat S; Sukeepaisarnjaroen W; Esteban JI; Bes M; Köhler B; Swiatek-de Lange M
World J Gastroenterol; 2022 Aug; 28(29):3917-3933. PubMed ID: 36157551
[TBL] [Abstract][Full Text] [Related]
11. Biology and significance of alpha-fetoprotein in hepatocellular carcinoma.
Galle PR; Foerster F; Kudo M; Chan SL; Llovet JM; Qin S; Schelman WR; Chintharlapalli S; Abada PB; Sherman M; Zhu AX
Liver Int; 2019 Dec; 39(12):2214-2229. PubMed ID: 31436873
[TBL] [Abstract][Full Text] [Related]
12. Biomarkers: evaluation of clinical utility in surveillance and early diagnosis for hepatocellular carcinoma.
Song P; Tang Q; Feng X; Tang W
Scand J Clin Lab Invest Suppl; 2016; 245():S70-6. PubMed ID: 27438343
[TBL] [Abstract][Full Text] [Related]
13. The 2008 Okuda lecture: Management of hepatocellular carcinoma: from surveillance to molecular targeted therapy.
Kudo M
J Gastroenterol Hepatol; 2010 Mar; 25(3):439-52. PubMed ID: 20370723
[TBL] [Abstract][Full Text] [Related]
14. Combination of triple biomarkers AFP, AFP-L3, and PIVAKII for early detection of hepatocellular carcinoma in China: Expectation.
Gao J; Song P
Drug Discov Ther; 2017; 11(3):168-169. PubMed ID: 28757516
[TBL] [Abstract][Full Text] [Related]
15. Circulating biomarkers in the diagnosis and management of hepatocellular carcinoma.
Johnson P; Zhou Q; Dao DY; Lo YMD
Nat Rev Gastroenterol Hepatol; 2022 Oct; 19(10):670-681. PubMed ID: 35676420
[TBL] [Abstract][Full Text] [Related]
16. AFP, PIVKAII, GP3, SCCA-1 and follisatin as surveillance biomarkers for hepatocellular cancer in non-alcoholic and alcoholic fatty liver disease.
Beale G; Chattopadhyay D; Gray J; Stewart S; Hudson M; Day C; Trerotoli P; Giannelli G; Manas D; Reeves H
BMC Cancer; 2008 Jul; 8():200. PubMed ID: 18638391
[TBL] [Abstract][Full Text] [Related]
17. Surveillance of cirrhosis for hepatocellular carcinoma: systematic review and economic analysis.
Thompson Coon J; Rogers G; Hewson P; Wright D; Anderson R; Cramp M; Jackson S; Ryder S; Price A; Stein K
Health Technol Assess; 2007 Sep; 11(34):1-206. PubMed ID: 17767898
[TBL] [Abstract][Full Text] [Related]
18. Human liver carboxylesterase 1 outperforms alpha-fetoprotein as biomarker to discriminate hepatocellular carcinoma from other liver diseases in Korean patients.
Na K; Jeong SK; Lee MJ; Cho SY; Kim SA; Lee MJ; Song SY; Kim H; Kim KS; Lee HW; Paik YK
Int J Cancer; 2013 Jul; 133(2):408-15. PubMed ID: 23319432
[TBL] [Abstract][Full Text] [Related]
19. Multiplex Immunochips for High-Accuracy Detection of AFP-L3% Based on Surface-Enhanced Raman Scattering: Implications for Early Liver Cancer Diagnosis.
Ma H; Sun X; Chen L; Cheng W; Han XX; Zhao B; He C
Anal Chem; 2017 Sep; 89(17):8877-8883. PubMed ID: 28770990
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of prothrombin induced by vitamin K absence, macrophage migration inhibitory factor and Golgi protein-73 versus alpha fetoprotein for hepatocellular carcinoma diagnosis and surveillance.
Ismail MM; Morsi HK; Abdulateef NA; Noaman MK; Abou El-Ella GA
Scand J Clin Lab Invest; 2017 May; 77(3):175-183. PubMed ID: 28276727
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
